HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco A Cassatella Selected Research

Marco A Cassatella Research Topics

Disease

16Inflammation (Inflammations)
04/2022 - 06/2002
10Neoplasms (Cancer)
01/2018 - 06/2002
6Infections
01/2016 - 11/2008
5Autoimmune Diseases (Autoimmune Disease)
01/2019 - 06/2006
3Chronic Obstructive Pulmonary Disease (COPD)
04/2022 - 09/2010
3Rheumatoid Arthritis
09/2010 - 01/2005
2Multiple Myeloma
01/2019 - 01/2017
2Virus Diseases (Viral Diseases)
01/2017 - 01/2016
2Psoriasis (Pustulosis Palmaris et Plantaris)
01/2017 - 02/2011
2Necrosis
01/2014 - 04/2008
2Melanoma (Melanoma, Malignant)
03/2013 - 11/2008
1Lung Diseases (Lung Disease)
04/2022
1Systemic Scleroderma (Systemic Sclerosis)
01/2019
1Chronic Mucocutaneous Candidiasis
08/2017
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017
1Bacterial Infections (Bacterial Infection)
01/2016
1Peritonitis
01/2016
1Vasculitis (Vasculitides)
11/2015
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
11/2015
1Carcinoma (Carcinomatosis)
01/2014
1Porcine Reproductive and Respiratory Syndrome (PRRS)
08/2013
1Arthritis (Polyarthritis)
05/2013
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
06/2011
1Crohn Disease (Crohn's Disease)
02/2011
1Osteoarthritis
09/2010
1Job Syndrome (Hyper-IgE Syndrome)
05/2010
1Myeloid Leukemia (Leukemia, Myelocytic)
06/2007
1Chronic Disease (Chronic Diseases)
06/2003
1Acute-Phase Reaction
06/2003
1Neoplasm Metastasis (Metastasis)
06/2002

Drug/Important Bio-Agent (IBA)

11CytokinesIBA
01/2020 - 06/2006
5Biological ProductsIBA
11/2018 - 06/2003
5Interleukin-10 (Interleukin 10)IBA
09/2015 - 04/2008
3LigandsIBA
06/2011 - 01/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2008 - 05/2004
3TNF-Related Apoptosis-Inducing LigandIBA
06/2006 - 05/2004
2DNA (Deoxyribonucleic Acid)IBA
08/2017 - 11/2008
2InterferonsIBA
01/2017 - 01/2006
2ChemokinesIBA
01/2016 - 01/2014
2EnzymesIBA
01/2016 - 01/2014
2Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2016 - 11/2010
2Messenger RNA (mRNA)IBA
08/2012 - 06/2007
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
05/2010 - 04/2008
1tanimilastIBA
04/2022
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
04/2022
1Phosphodiesterase 4 InhibitorsIBA
04/2022
1Endothelin-1 (Endothelin 1)IBA
01/2019
1Long Noncoding RNAIBA
01/2019
1emactuzumabIBA
01/2018
1STAT1 Transcription FactorIBA
08/2017
1AntigensIBA
01/2017
1Secretory Phospholipases A2IBA
01/2017
1Endothelin A ReceptorIBA
01/2017
1Imiquimod (Aldara)FDA LinkGeneric
01/2017
1Neprilysin (Neutral Endopeptidase)IBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
01/2016
1Antiviral Agents (Antivirals)IBA
01/2016
1ZymosanIBA
01/2016
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2015
1Myeloblastin (Proteinase 3)IBA
11/2015
1Pattern Recognition ReceptorsIBA
08/2013
1Pathogen-Associated Molecular Pattern MoleculesIBA
08/2013
1Staphylococcal Protein A (Protein A)IBA
05/2013
1MicroRNAs (MicroRNA)IBA
03/2009
1Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2008
1Poly I-CIBA
11/2008
1RNA Helicases (RNA Helicase)IBA
11/2008
1Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA
06/2007
1Rheumatoid FactorIBA
06/2007
1Antigen-Antibody Complex (Immune Complex)IBA
06/2007
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2005
1Acute-Phase Proteins (Acute-Phase Protein)IBA
06/2003
1Interleukin-8 (Interleukin 8)IBA
06/2003
1AngiostatinsIBA
06/2002

Therapy/Procedure

1Immunomodulation
01/2006